Competency information
Details
Select the appropriate diagnostic pathway for patients with a suspected diagnosis of the following conditions :
- CML
- CLL
- Ph-negative myeloproliferative malignancies
- Burkitt lymphoma
Considerations
- WHO classification of the relevant disorders Usual clinical features of the relevant disorders
- Morphological features of the peripheral blood film,bone marrow aspirate, bone marrow trephine or lymph node biopsy (as appropriate) for the relevant disorders
- Immunophenotypic features, where relevant, of the disorders
- Interaction between different laboratory and clinical approaches for diagnosis
- Factors affecting sample quality and suitability for examinations
- Factors to be considered when limited material is available to allow diagnosis and ongoing monitoring
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 | Outcome Using the examples of myeloproliferative neoplasms, chronic myeloid leukaemia, chronic lymphocytic leukaemiaand Burkitt lymphoma: |
| # 2 | Outcome Interact with relevant disciplines for the diagnosis and treatment of haematological malignancies |
| # 3 | Outcome Apply the appropriate testing strategy that would lead to the diagnosis of a range haematological malignancies |